These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4355680)

  • 1. Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice.
    Potter M; Sklar MD; Rowe WP
    Science; 1973 Nov; 182(4112):592-4. PubMed ID: 4355680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell populations and known surface antigens of tumors induced by Abelson virus in pristane-primed BALB/c mice: an analysis by immunoelectron microscopy;
    Aoki T; Potter M; Sturm MM; Liu M; Walling MJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1097-106. PubMed ID: 173861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
    Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
    J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pristane-treated BALB/c mice.
    Sugiyama H; Weber G; Silva S; Babonits M; Wiener F; Klein G
    Int J Cancer; 1989 Aug; 44(2):348-52. PubMed ID: 2547729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
    Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
    Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus.
    Clynes R; Wax J; Stanton LW; Smith-Gill S; Potter M; Marcu KB
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6067-71. PubMed ID: 3137564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice.
    Silva S; Wang Y; Babonits M; Imreh S; Wiener F; Klein G
    Eur J Cancer; 1997 Mar; 33(3):479-85. PubMed ID: 9155535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid induction of plasmacytomas in mice by pristane and a murine recombinant retrovirus containing an avian v-myc and a defective raf oncogene.
    Potter M; Wax J; Mushinski E; Brust S; Babonits M; Wiener F; Mushinski JF; Mezebish D; Skurla R; Rapp U
    Curr Top Microbiol Immunol; 1986; 132():40-3. PubMed ID: 3792042
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M; Wax JS
    J Natl Cancer Inst; 1983 Aug; 71(2):391-5. PubMed ID: 6576197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytomas of the NZB mouse.
    Morse HC; Riblet R; Asofsky R; Weigert M
    J Immunol; 1978 Nov; 121(5):1969-72. PubMed ID: 712074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic-mass spectrometric investigation of four commercial pristane (2.6.10.14-tetramethylpentadecane) preparations used for plasmacytoma induction in BALB/c mice.
    Janz S; Birkenfeld T; Herzschuh R; Storch H
    Arch Geschwulstforsch; 1989; 59(6):415-22. PubMed ID: 2596957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoma induction in radiochimeras.
    Silva S; Babonits M; Wiener F; Klein G
    Int J Cancer; 1989 Aug; 44(2):337-42. PubMed ID: 2759740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrovirus expressing v-abl and c-myc induces plasmacytomas in 100% of adult pristane-primed BALB/c mice.
    Weissinger EM; Largaespada D; Smith-Gill SJ; Risser R; Mushinski JF; Mischak H
    Curr Top Microbiol Immunol; 1990; 166():121-7. PubMed ID: 2073789
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
    Potter M; Wax JS; Anderson AO; Nordan RP
    J Exp Med; 1985 May; 161(5):996-1012. PubMed ID: 3989472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.
    Potter M; Wax JS
    J Immunol; 1981 Oct; 127(4):1591-5. PubMed ID: 7276572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice.
    Janz S; Shacter E
    Cancer Biochem Biophys; 1995 Jun; 15(1):25-34. PubMed ID: 8536217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
    J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
    Oikawa T; Kuzumaki N; Yamada T
    J Natl Cancer Inst; 1984 Feb; 72(2):347-53. PubMed ID: 6582321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.
    Shen-Ong GL; Wolff L
    J Virol; 1987 Dec; 61(12):3721-5. PubMed ID: 2824810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.